317 related articles for article (PubMed ID: 19514091)
41. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer.
Kagedan DJ; Abraham L; Goyert N; Li Q; Paszat LF; Kiss A; Earle CC; Mittmann N; Coburn NG
Cancer; 2016 Oct; 122(20):3175-3182. PubMed ID: 27391466
[TBL] [Abstract][Full Text] [Related]
42. Has survival improved following resection for pancreatic adenocarcinoma?
Luberice K; Downs D; Sadowitz B; Ross S; Rosemurgy A
Am J Surg; 2017 Aug; 214(2):341-346. PubMed ID: 28601189
[TBL] [Abstract][Full Text] [Related]
43. A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival.
Wray CJ; Castro-Echeverry E; Silberfein EJ; Ko TC; Kao LS
Ann Surg Oncol; 2012 Sep; 19(9):2776-81. PubMed ID: 22526908
[TBL] [Abstract][Full Text] [Related]
44. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
45. Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries.
Miura JT; Evans DB; Pappas SG; Gamblin TC; Turaga KK
Ann Surg Oncol; 2013 Dec; 20(13):4338-47. PubMed ID: 24002538
[TBL] [Abstract][Full Text] [Related]
46. Impact of Race/Ethnicity and County-Level Vulnerability on Receipt of Surgery Among Older Medicare Beneficiaries With the Diagnosis of Early Pancreatic Cancer.
Azap RA; Diaz A; Hyer JM; Tsilimigras DI; Mirdad RS; Ejaz A; Pawlik TM
Ann Surg Oncol; 2021 Oct; 28(11):6309-6316. PubMed ID: 33844130
[TBL] [Abstract][Full Text] [Related]
47. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
McBride R; Hershman D; Tsai WY; Jacobson JS; Grann V; Neugut AI
Cancer; 2007 Sep; 110(6):1201-8. PubMed ID: 17701948
[TBL] [Abstract][Full Text] [Related]
48. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
49. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
[TBL] [Abstract][Full Text] [Related]
50. Regional variation in racial disparities among patients with peripheral artery disease.
O'Donnell TFX; Powell C; Deery SE; Darling JD; Hughes K; Giles KA; Wang GJ; Schermerhorn ML
J Vasc Surg; 2018 Aug; 68(2):519-526. PubMed ID: 29459014
[TBL] [Abstract][Full Text] [Related]
51. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
52. Thirty-day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
Mitsakos AT; Dennis SO; Parikh AA; Snyder RA
J Surg Oncol; 2021 Mar; 123(4):970-977. PubMed ID: 33497474
[TBL] [Abstract][Full Text] [Related]
53. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
54. Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009.
Loja MN; Brunson A; Li CS; Carson JG; White RH; Romano PS; Hedayati N
Ann Vasc Surg; 2015 Jul; 29(5):950-9. PubMed ID: 25757991
[TBL] [Abstract][Full Text] [Related]
55. Differences in Baseline Characteristics and White Blood Cell Ratios Between Racial Groups in Patients with Pancreatic Adenocarcinoma.
Ueberroth BE; Khan A; Zhang KJ; Philip PA
J Gastrointest Cancer; 2021 Mar; 52(1):160-168. PubMed ID: 32077005
[TBL] [Abstract][Full Text] [Related]
56. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
57. Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system.
Lee S; Reha JL; Tzeng CW; Massarweh NN; Chang GJ; Hetz SP; Fleming JB; Lee JE; Katz MH
Ann Surg Oncol; 2013 Dec; 20(13):4073-9. PubMed ID: 24002535
[TBL] [Abstract][Full Text] [Related]
58. National failure to operate on early stage pancreatic cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS
Ann Surg; 2007 Aug; 246(2):173-80. PubMed ID: 17667493
[TBL] [Abstract][Full Text] [Related]
59. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
[TBL] [Abstract][Full Text] [Related]
60. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
